Sanggenon B is primarily studied for its potential biological activities, particularly in the field of pharmacology. It exhibits strong antioxidant properties, helping to neutralize free radicals and reduce oxidative stress in cells. This makes it a candidate for research in neurodegenerative diseases such as Alzheimer’s, where oxidative damage plays a key role.

It also shows anti-inflammatory effects by inhibiting pro-inflammatory cytokines and signaling pathways like NF-κB. This suggests possible use in managing chronic inflammatory conditions. Additionally, Sanggenon B has demonstrated antimicrobial and antiviral activity in preliminary studies, indicating potential for development in infectious disease treatments.

Research highlights its ability to induce apoptosis in certain cancer cell lines, pointing to anticancer potential, especially in liver and breast cancer models. Due to its polyphenolic structure, it may support metabolic health by improving insulin sensitivity and lipid metabolism, making it relevant in diabetes and obesity-related research.

Most applications are still in the preclinical stage, based on in vitro and animal studies. Further research is needed to evaluate bioavailability, safety, and efficacy in humans.